Ultra‐rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy
- 1 June 2006
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 36 (6) , 704-713
- https://doi.org/10.1111/j.1365-2222.2006.02487.x
Abstract
Background Venom immunotherapy (VIT) induces immune tolerance to hymenoptera venom antigens in allergic patients and is therefore a helpful model for studying modulation of allergic immune response. The objectives were to assess the early effects of ultra-rush VIT on T lymphocyte activation and regulatory profile induction, in all subjects combined and according to the four severity grades of the Mueller classification. Materials and Methods Blood samples from 30 vespid-allergic patients were taken before and after the first day of treatment, and before day 15 and day 45 booster injections. IFN-γ and IL-4 levels were assayed by ELISA, in whole-blood supernatants. IFN-γ and IL-13-producing T cells, but also natural CD4+CD25+high regulatory T cells and acquired regulatory T cell proportions were assessed by flow cytometry. Results were analysed in the whole population and compared between patients with I–II or III–IV allergic reactions. Results During VIT, IFN-γ increased in whole blood when IL-4 decreased. Among T cells, the percentage of CD3+IFN-γ+ cells increased while IL-13-producing T cells decreased. Proportions of CD4+CD25+high cells and IL-10-producing T cells increased with VIT. In I–II subjects, IFN-γ increased gradually, whereas it remained at low levels in III–IV patients. By contrast, IL-4 decrease was more pronounced in III–IV patients. Increase in CD4+CD25+high T cells occurred early in I–II patients but was delayed in III–IV patients. IL-10-producing T cells increased gradually in both groups but were in a lower proportion in III–IV patients. Conclusion A T helper type 2 (Th2)-to-Th1 switch occurs during ultra-rush VIT, in parallel with natural and acquired regulatory T cell increase. These events occur earlier and at a higher level in less severe subjects, suggesting that VIT tolerance induction is easier to achieve in these patients.Keywords
This publication has 42 references indexed in Scilit:
- T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory ActivityPLoS Medicine, 2005
- Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4+CD25+ interleukin‐10+ T cells expressing peripheral tissue trafficking markersClinical and Experimental Allergy, 2004
- Mechanisms of immunotherapyJournal of Allergy and Clinical Immunology, 2004
- In vitro testing to diagnose venom allergy and monitor immunotherapy: a placebo‐controlled, crossover trialClinical and Experimental Allergy, 2004
- Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapyImmunology, 2004
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- Instruction for Cytokine Expression in T Helper Lymphocytes in Relation to Proliferation and Cell Cycle ProgressionThe Journal of Experimental Medicine, 1999
- Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cellsJournal of Allergy and Clinical Immunology, 1999
- Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH‐1 or TH‐2‐like cytokine patternsClinical and Experimental Allergy, 1995
- Rapid Hymenoptera venom immunotherapy: comparative safety of three protocolsClinical and Experimental Allergy, 1993